A Model Information Management Plan for Molecular Pathology Sequence Data Using Standards: From Sequencer to Electronic Health Record.


Journal

The Journal of molecular diagnostics : JMD
ISSN: 1943-7811
Titre abrégé: J Mol Diagn
Pays: United States
ID NLM: 100893612

Informations de publication

Date de publication:
05 2019
Historique:
received: 13 03 2018
revised: 10 11 2018
accepted: 04 12 2018
pubmed: 24 2 2019
medline: 19 6 2020
entrez: 24 2 2019
Statut: ppublish

Résumé

Incorporating genetic variant data into the electronic health record (EHR) in discrete computable fashion has vexed the informatics community for years. Genetic sequence test results are typically communicated by the molecular laboratory and stored in the EHR as textual documents. Although text documents are useful for human readability and initial use, they are not conducive for data retrieval and reuse. As a result, clinicians often struggle to find historical gene sequence results on a series of oncology patients within the EHR that might influence the care of the current patient. Second, identification of patients with specific mutation results in the EHR who are now eligible for new and/or changing therapy is not easily accomplished. Third, the molecular laboratory is challenged to monitor its sequencing processes for nonrandom process variation and other quality metrics. A novel approach to address each of these issues is presented and demonstrated. The authors use standard Health Level 7 laboratory result message formats in conjunction with international standards, Systematized Nomenclature of Medicine Clinical Terms and Human Genome Variant Society nomenclature, to represent, communicate, and store discrete gene sequence data within the EHR in a scalable fashion. This information management plan enables the support of the clinician at the point of care, enhances population management, and facilitates audits for maintaining laboratory quality.

Identifiants

pubmed: 30797065
pii: S1525-1578(18)30113-2
doi: 10.1016/j.jmoldx.2018.12.002
pmc: PMC6521887
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

408-417

Subventions

Organisme : NHGRI NIH HHS
ID : U01 HG009455
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2019 American Society for Investigative Pathology and the Association for Molecular Pathology. Published by Elsevier Inc. All rights reserved.

Références

Nat Genet. 2000 May;25(1):25-9
pubmed: 10802651
Br J Cancer. 2004 Jul 19;91(2):355-8
pubmed: 15188009
Stud Health Technol Inform. 2004;107(Pt 1):273-6
pubmed: 15360817
Pac Symp Biocomput. 2005;:139-50
pubmed: 15759621
Methods Inf Med. 2005;44(4):546-50
pubmed: 16350276
Hosp Health Netw. 2009 Jul;83(7):20, 22
pubmed: 19711534
BMC Bioinformatics. 2010 Oct 28;11 Suppl 9:S10
pubmed: 21044357
Hum Mutat. 2011 May;32(5):532-6
pubmed: 21432942
Bioinformatics. 2011 Aug 1;27(15):2156-8
pubmed: 21653522
J Biomed Inform. 2012 Feb;45(1):82-92
pubmed: 21946299
J Biomed Inform. 2012 Jun;45(3):419-22
pubmed: 22223081
Genome Med. 2012 Jul 30;4(7):61
pubmed: 22839973
Nucleic Acids Res. 2014 Jan;42(Database issue):D980-5
pubmed: 24234437
Nucleic Acids Res. 2015 Jan;43(Database issue):D789-98
pubmed: 25428349
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
N Engl J Med. 2015 Jun 4;372(23):2235-42
pubmed: 26014595
J Am Med Inform Assoc. 2015 Nov;22(6):1231-42
pubmed: 26142422
Cancers (Basel). 2015 Jul 17;7(3):1313-32
pubmed: 26193321
J Am Med Inform Assoc. 2015 Nov;22(6):1173-8
pubmed: 26198304
Mol Cancer Ther. 2015 Dec;14(12):2887-95
pubmed: 26438153
Hum Mutat. 2016 Jun;37(6):564-9
pubmed: 26931183
EGEMS (Wash DC). 2016 Apr 19;4(1):1198
pubmed: 27195307
Arch Pathol Lab Med. 2016 Jun;140(6):578-87
pubmed: 27232350
Nature. 2016 Aug 17;536(7616):285-91
pubmed: 27535533
Genome Med. 2016 Oct 26;8(1):113
pubmed: 27784327
J Mol Diagn. 2017 Jan;19(1):4-23
pubmed: 27993330
Nat Genet. 2017 Mar;49(3):332-340
pubmed: 28092685
Genome Med. 2017 Jan 26;9(1):7
pubmed: 28122645
AMIA Annu Symp Proc. 2017 Feb 10;2016:352-360
pubmed: 28269830
J Clin Oncol. 2017 Sep 20;35(27):3153-3159
pubmed: 28737972
J Am Med Inform Assoc. 2017 Sep 13;:null
pubmed: 29024958
Nucleic Acids Res. 2018 Mar 16;46(5):2699
pubmed: 29425356
Genomics. 1997 Oct 15;45(2):468-71
pubmed: 9344684

Auteurs

Walter S Campbell (WS)

Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, Nebraska. Electronic address: wcampbel@unmc.edu.

Alexis B Carter (AB)

Department of Pathology, Children's Healthcare of Atlanta, Atlanta, Georgia.

Allison M Cushman-Vokoun (AM)

Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, Nebraska.

Timothy C Greiner (TC)

Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, Nebraska.

Rajesh C Dash (RC)

Department of Pathology, Duke University Health System, Durham, North Carolina.

Mark Routbort (M)

Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, Texas.

Monica E de Baca (ME)

Medical Laboratory Associates, Lynnwood, Washington.

James R Campbell (JR)

Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH